Eli Lilly became the first drugmaker to reach a $1 trillion market valuation on Friday, driven by the rapid growth of its ...

Eli Lilly hit a $1 trillion valuation, driven by demand for Zepbound and Mounjaro. The first health-care firm ever to join ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly becomes the first healthcare firm to hit $1T, powered by GLP-1 dominance, surging sales, and strong investor ...

While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...

The market has been swinging recently, with the S&P 500 index down 1.5% and the Nasdaq Composite down more than 2% over the ...

Eli Lilly achieved a historic milestone, briefly touching a $1 trillion market cap. This success is driven by strong sales of ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

The Indianapolis drug giant's stock (LLY) reached an intraday high of $1,061.17 in morning trading Friday, which was above the threshold of $1,057.78 needed for Lilly to become the 10th U.S. company ...

In summary, under the Trump plan, the U.S. health system continues to fail Americans — by not viewing obesity as a disease, ...

Health, a leader in virtual cardiometabolic care, today announced a new offering designed to make access to obesity management medications and care more sustainable for employers. The "No-Barriers ...

Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid ...